Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 162

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-26-7_006

تاریخ نمایه سازی: 17 خرداد 1402

Abstract:

Objective(s): Colon cancer is well-known as a life-threatening disease. Since the current treatment modalities for this type of cancer are powerful yet face some limitations, finding novel treatments is required to achieve better outcomes with fewer side effects. Here we investigated the therapeutic potential of Azurin-p۲۸ alone or along with iRGD (Ac-CRGDKGPDC-amide) as a tumor-penetrating peptide and ۵-fluorouracil (۵-FU) for colon cancer. Materials and Methods: Inhibitory effect of p۲۸ with or without iRGD/۵-FU was studied in CT۲۶ and HT۲۹, as well as the xenograft animal model of cancer. The effect of p۲۸ alone or along with iRGD/۵-FU on cell migration, apoptotic activity, and cell cycle of the cell lines was assessed. Level of the BAX and BCL۲ genes, tumor suppressor genes [(p۵۳ and collagen type-Iα۱ (COL۱A۱), collagen type-Iα۲ (COL۱A۲)] were assessed by quantitative RT-PCR.Results: These findings show that using p۲۸ with or without iRGD and ۵-FU raised the level of p۵۳ and BAX but decreased BCL۲, compared with control and ۵-FU groups in tissues of the tumor, which result in raising the apoptosis. Conclusion: It seems that p۲۸ may be used as a new therapeutic approach in colon cancer therapy that can enhance the anti-tumor effect of ۵-FU.

Authors

Atieh Yaghoubi

Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Aref Movaqar

Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Fereshteh Asgharzadeh

Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad Derakhshan

Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Kiarash Ghazvini

Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Seyed Mahdi Hasanian

Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical, Sciences, Mashhad, Iran

Amir Avan

Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Asma Mostafapour

Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran

Majid Khazaei

Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Saman Soleimanpour

Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, ...
  • Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis ...
  • Portilla AG, Cendoya I, De Tejada IL, Olabarria I, de ...
  • Lemoine L, Sugarbaker P, Van der Speeten K. Pathophysiology of ...
  • Sugarbaker PH. Improving oncologic outcomes for colorectal cancer at high ...
  • Symeonidis D, Christodoulidis G, Koukoulis G, Spyridakis M, Tepetes K. ...
  • Groza D, Gehrig S, Kudela P, Holcmann M, Pirker C, ...
  • Nemunaitis J, Cunningham C, Senzer N, Kuhn J, Cramm J, ...
  • Heimann DM, Rosenberg SA. Continuous intravenous administration of live genetically ...
  • Yu K-H, Zhang C, Berry GJ, Altman RB, Ré C, ...
  • Nauts HC, Swift WE, Coley BL. The treatment of malignant ...
  • Gontero P, Bohle A, Malmstrom P-U, O’Donnell MA, Oderda M, ...
  • Zlotta AR, Fleshner NE, Jewett MA. The management of BCG ...
  • J Boohaker R, W Lee M, Vishnubhotla P, LM Perez ...
  • Karpiński TM, Adamczak A. Anticancer activity of bacterial proteins and ...
  • Anson ML, Edsall JT. Interactions of antimicrobial peptides with bacterial ...
  • Marqus S, Pirogova E, Piva TJ. Evaluation of the use ...
  • Fialho AM, Bernardes N, Chakrabarty AM. Exploring the anticancer potential ...
  • Yaghoubi A, Khazaei M, Avan A, Hasanian SM, Cho WC, ...
  • Beattie CW, Yamada T, Gupta TKD. Compositions and methods to ...
  • Garizo AR, Bernardes N, Chakrabarty AM, Fialhoa AM. The anticancer ...
  • Mehta RR, Yamada T, Taylor BN, Christov K, King ML, ...
  • Sugahara KN TT, Karmali PP, Kotamraju VR, Agemy L, Greenwald ...
  • Teesalu T SK, Kotamraju VR, Ruoslahti E. C-end rule peptides ...
  • Yamada T, Gupta TKD, Beattie CW. p۲۸-mediated activation of p۵۳ ...
  • Hamilton AM, Aidoudi-Ahmed S, Sharma S, Kotamraju VR, Foster PJ, ...
  • Marjaneh RM, Rahmani F, Hassanian SM, Rezaei N, Hashemzehi M, ...
  • Carbone L, Carbone ET, Yi EM, Bauer DB, Lindstrom KA, ...
  • Amerizadeh F, Rezaei N, Rahmani F, Hassanian SM, Moradi‐Marjaneh R, ...
  • Marjaneh RM, Rahmani F, Hassanian SM, Rezaei N, Hashemzehi M, ...
  • Elmi S, Sallam NA, Rahman MM, Teng X, Hunter AL, ...
  • Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, ...
  • Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, ...
  • Wang J-L, Liu D, Zhang Z-J, Shan S, Han X, ...
  • Niazi S, Purohit M, Niazi JH. Role of p۵۳ circuitry ...
  • Valente JF, Queiroz JA, Sousa F. p۵۳ as the focus ...
  • Yamada T, Goto M, Punj V, Zaborina O, Kimbara K, ...
  • Punj V, Bhattacharyya S, Saint-Dic D, Vasu C, Cunningham EA, ...
  • Huang Y, Zhou J, Cheng X, Su Z. Deciphering the ...
  • Sheibani N, Newman P, Frazier W. Thrombospondin-۱, a natural inhibitor ...
  • Wu J, Sheibani N. Modulation of VE‐cadherin and PECAM‐۱ mediated ...
  • Koga Y, Pelizzola M, Cheng E, Krauthammer M, Sznol M, ...
  • Mori K, Enokida H, Kagara I, Kawakami K, Chiyomaru T, ...
  • Shin K, Lim A, Zhao C, Sahoo D, Pan Y, ...
  • Shin K, Lee J, Guo N, Kim J, Lim A, ...
  • Zou X, Feng B, Dong T, Yan G, Tan B, ...
  • Liang Y, Diehn M, Bollen AW, Israel MA, Gupta N. ...
  • Gao F, Li M, Xiang R, Zhou X, Zhu L, ...
  • Lin P, Tian P, Pang J, Lai L, He G, ...
  • Mestdagt M, Polette M, Buttice G, Noël A, Ueda A, ...
  • Yoshidome H, Kohno H, Shida T, Kimura F, Shimizu H, ...
  • Xu M, Wang S, Qi Y, Chen L, Frank JA, ...
  • Haabeth OAW, Lorvik KB, Hammarström C, Donaldson IM, Haraldsen G, ...
  • Haabeth OAW, Lorvik KB, Yagita H, Bogen B, Corthay A. ...
  • North R, Neubauer RH, Huang J, Newton RC, Loveless SE. ...
  • Warso M, Richards J, Mehta D, Christov K, Schaeffer C, ...
  • Lulla RR, Goldman S, Yamada T, Beattie CW, Bressler L, ...
  • نمایش کامل مراجع